![]() Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). | ||
Founding Date | Founding Date 2006 | Founding Date 1997 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Paris, FR HQ | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US |
Employees | Employees 233% decrease | Employees 1652% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) NT$101.9m (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit NT$129.8m (FY, 2020) |
Net income | Net income (€8.9m) (FY, 2024) | Net income (NT$983.3m) (FY, 2020) |

Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View company